Patents by Inventor Chang An Chu

Chang An Chu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7842825
    Abstract: The present invention relates to compounds of formula (I) wherein R1, R2, R3, R4, m, n, p and s are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases that are associated with the activation of the glycogen synthase enzyme, such as diabetes.
    Type: Grant
    Filed: June 13, 2008
    Date of Patent: November 30, 2010
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Chang An Chu, Paul Gillespie, Jefferson Wright Tilley
  • Patent number: 7700632
    Abstract: The present invention relates to compounds of formula (I) wherein R1, R2, R3, R4, m, n, p and s are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases that are associated with the activation of the glycogen synthase enzyme, such as diabetes.
    Type: Grant
    Filed: January 8, 2008
    Date of Patent: April 20, 2010
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Chang An Chu, Paul Gillespie, Jefferson Wright Tilley
  • Publication number: 20080255198
    Abstract: The present invention relates to compounds of formula (I) wherein R1, R2, R3, R4, m, n, p and s are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases that are associated with the activation of the glycogen synthase enzyme, such as diabetes.
    Type: Application
    Filed: June 13, 2008
    Publication date: October 16, 2008
    Inventors: Chang An Chu, Paul Gillespie, Jefferson Wright Tilley
  • Patent number: 7355049
    Abstract: The present invention relates to compounds of formula (I) wherein R1, R2, R3, R4, m, n, p and s are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases that are associated with the activation of the glycogen synthase enzyme, such as diabetes.
    Type: Grant
    Filed: June 17, 2004
    Date of Patent: April 8, 2008
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Chang An Chu, Paul Gillespie, Jefferson Wright Tilley
  • Publication number: 20040266856
    Abstract: The present invention relates to compounds of formula (I) 1
    Type: Application
    Filed: June 17, 2004
    Publication date: December 30, 2004
    Inventors: Chang An Chu, Paul Gillespie, Jefferson Wright Tilley